Marathon Money Podcast - Roll With Marathon Money and Win the Stock Market Race · Marathon Money Podcast - Roll With Marathon Money and Win the Stock Market Race

Envoy Medical (Nasdaq: COCH) Nears Critical FDA Decision: Could Q1 2026 Spark Revenue Growth?

·29 min·1 clip

Envoy's sensor sits on the incus bone, which Brent calls 'nature's microphone.'

1. Marathon Money Podcast focuses on Envoy Medical and the Acclaim fully implanted cochlear implant as Brent discusses FDA approval and market strategy. 2. Brent is the CEO of Envoy Medical, and the host presses him on valuation, sales, surgery, AI, and competition. 3. The episode asks whether Envoy can turn a small market cap and a long FDA process into a large hearing-implant business. 4. Brent says the company is on its '20 mile march' toward FDA approval and has enrolled 10 patients in a pivotal clinical trial. 5. He says Envoy plans to submit an FDA expansion request and thinks it could arrive in the next couple of months or later in the quarter. 6. After approval, Brent says Envoy would target Cochlear Limited, the Australian market leader in hearing implants. 7. He argues the hearing implant market is under-penetrated and says the company wants to educate patients about a fully implanted, invisible option. 8. Brent says the main differentiator is a sensor that picks up sound vibrations from the incus bone behind the eardrum. 9. He contrasts that design with microphones outside the ear and says the company is trademarking 'nature's microphone.' 10. Brent says the same sensor was used in the earlier Esteem device and gives Envoy 20 years of clinical data, manufacturing, and implantation know-how. 11. He says Envoy wants about three to four dozen sites ready in the first year after approval, with surgeons and audiologists already being recruited at conferences. 12. Brent compares that rollout to Intuitive Surgical's center-by-center expansion and warns against spreading too thin across too many centers. 13. He says the Acclaim device is built to last for the patient's lifetime and is investigational until commercially approved. 14. Brent says the design includes firmware that could let the device be upgraded without taking it out of the body. 15. He says the battery pack sits in the chest, which gives the device more capacity for future features. 16. Brent says that setup could help Envoy work alongside consumer electronics such as AirPods, noise cancellation, translation, and future AI features. 17. The conversation is direct and sales-focused, with Brent repeating valuation, adoption, and moat arguments several times. 18. The host is energetic and skeptical in places, but the tone stays optimistic about FDA approval and market expansion. 19. Listeners interested in medtech investing and hearing devices. 20. Listeners looking for clinical detail instead of market speculation.

As heard by us

A trading-room style look at Envoy Medical's long FDA wait and the business it could unlock.

Marathon Money spends most of its time on Envoy Medical's slow FDA path and what that approval might mean for the business. The host keeps coming back to the same pressure point: can a company like this turn a long regulatory wait into something real in a market that is already…

Read the full review in PlayNext →

Why you'd press play

If you want the FDA approval march behind a long-shot cochlear implant, press play.

Read the full recommendation in PlayNext →

Listen to the show on

Apple Podcasts Spotify

Play clips from this episode More from Marathon Money Podcast - Roll With Marathon Money and Win the Stock Market Race